925 Chestnut Street
Suite 320A
Philadelphia, PA 19107
(215) 955-8874
Suite 320A
Philadelphia, PA 19107
(215) 955-8874
Most Recent Peer-reviewed Publications
- A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
- A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- Epithelial-to-mesenchymal transition and cellular membrane receptors in ovarian cancer: Moving forward in the era of molecularly targeted therapy
- A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study
- mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary
Medical School
University of Miami School of Medicine - 1983
Residency
Temple University Hospital
Fellowship
Temple University Hospital
Board Certification
Medical Oncology
Hematology
Internal Medicine
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
University Appointment
Director, Gynecologic Medical Oncology
Professor
Research & Clinical Interests
Medical Oncology